Tyme Technologies, Inc. – NASDAQ:TYME

Add to watchlist

$0.311

Market closed

Open in 1 day

-11.14%

month

+24.40%

quarter

-70.10%

year

Market Cap	N/A
Enterprise value	47.11M

P/E	-2.26
EV/Sales	N/A
EV/EBITDA	-2.20
Price/Sales	N/A
Price/Book	0.72
PEG ratio	-0.06
EPS	-0.13

Revenue	N/A
EBITDA	-21.69M
Income	-23.39M
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Tyme Technologies, Inc. (NASDAQ:TYME): Profit margin
Jun 2021	0	-5.92M
Sep 2021	0	-5.56M
Dec 2021	0	-5.33M
Mar 2022	0	-6.57M

Tyme Technologies, Inc. (NASDAQ:TYME): Debt to assets
Sep 2021	97806642	6.29M	6.44%
Dec 2021	93000817	6.31M	6.79%
Mar 2022	88015185	7.93M	9.01%
Jun 2022	80161711	6.02M	7.51%

Tyme Technologies, Inc. (NASDAQ:TYME): Cash Flow
Jun 2021	-5.80M	-65.25M	6.18K
Sep 2021	-4.47M	-2.77M	0
Dec 2021	-3.75M	-4.65M	6.18K
Mar 2022	-7.20M	144.06K	0

Tyme Technologies alternative data

Social Media

🎓 Academy: How impactful can social media data be in investment decisions

Tyme Technologies, Inc. (NASDAQ:TYME): Employee count
Aug 2023	13
Sep 2023	13
Oct 2023	13
Nov 2023	13
Dec 2023	13
Jan 2024	13
Feb 2024	13
Mar 2024	13
Apr 2024	13
May 2024	13
Jun 2024	13
Jul 2024	13

Tyme Technologies
Hedge Funds Holdings Q1 2022

7.36% -0.58%

of TYME is owned by hedge funds

48 -7

hedge funds hold TYME stock

12.67M -998.83K

shares is hold by hedge funds

TYME hedge funds holdings changes

Tyme Technologies
Insider Trading

Tyme Technologies, Inc. (NASDAQ:TYME): Insider trades (number of shares)
Period	Buy	Sel
Oct 2021	0	392500
Nov 2021	30000	381880
Dec 2021	10000	412500
Jan 2022	0	392820
Feb 2022	27022	392500
Mar 2022	0	392500
Apr 2022	0	432500
May 2022	0	565597
Jun 2022	0	619403
Jul 2022	0	280000
Aug 2022	0	160000
Sep 2022	0	160000

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Sale	7 Sep 2022	DEMURJIAN MICHAEL 10 percent owner 10 percent owner	Common Stock	80,000	$0.24	$19,360
Sale	6 Sep 2022	DEMURJIAN MICHAEL 10 percent owner 10 percent owner	Common Stock	80,000	$0.26	$21,120
Sale	23 Aug 2022	DEMURJIAN MICHAEL 10 percent owner 10 percent owner	Common Stock	80,000	$0.29	$23,440
Sale	22 Aug 2022	DEMURJIAN MICHAEL 10 percent owner 10 percent owner	Common Stock	80,000	$0.29	$23,440
Sale	26 Jul 2022	DEMURJIAN MICHAEL 10 percent owner 10 percent owner	Common Stock	70,000	$0.3	$20,650
Sale	25 Jul 2022	DEMURJIAN MICHAEL 10 percent owner 10 percent owner	Common Stock	70,000	$0.29	$20,440
Sale	12 Jul 2022	DEMURJIAN MICHAEL 10 percent owner 10 percent owner	Common Stock	70,000	$0.29	$20,020
Sale	11 Jul 2022	DEMURJIAN MICHAEL 10 percent owner 10 percent owner	Common Stock	70,000	$0.29	$20,020
Sale	28 Jun 2022	DEMURJIAN MICHAEL 10 percent owner 10 percent owner	Common Stock	60,000	$0.27	$16,080
Sale	27 Jun 2022	DEMURJIAN MICHAEL 10 percent owner 10 percent owner	Common Stock	60,000	$0.26	$15,720

TYME insider trading transactions

Tyme Technologies
Earnings Call Transcripts

Quarter	Transcript
Q3 2022 11 Feb 2022	Q3 2022 Earnings Call Transcript
Q2 2021 8 Nov 2021	Q2 2021 Earnings Call Transcript
Q1 2021 10 Jun 2021	Q1 2021 Earnings Call Transcript
Q4 2020 21 May 2020	Q4 2020 Earnings Call Transcript

TYME earnings call transcripts

Tyme Technologies
Executives

Insider	Age	Compensation
Mr. Steven E. Hoffman (1963) Co-Founder, Chairman & Chief Science Officer	62	$819,660
Mr. James Biehl J.D. (1964) Chief Legal Officer & Sec.	61	$645,520
Dr. Jonathan M. Eckard (1974) Chief Bus. Officer	51	$556,560
Mr. Richard Cunningham (1971) Chief Executive Officer & Director	54	$355,970

Tyme Technologies
Latest News

Tuesday, 17 December 2024
10:59	Nubank Helps Digital Lender Tyme Reach $1.5 Billion Valuation	pymnts.com
02:10	Brazilian digital lender Nubank invests $150 million in Tyme Group	reuters.com
Monday, 16 December 2024
18:15	Nubank Announces Investment in Tyme Group, a Digital Bank With Operations in South Africa and the Philippines	businesswire.com
Wednesday, 6 July 2022
11:23	SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Tyme Technologies, Inc. Merger	newsfilecorp.com
Tuesday, 5 July 2022
20:50	SHAREHOLDER ALERT: Weiss Law Investigates Syros Pharmaceuticals, Inc.	prnewswire.com
09:15	Penny Stocks To Watch: Why KRKR, RMED, TYME, TTNP & ENDP Stock Are Moving	PennyStocks
08:16	TYME Technologies Shares Surge On Merger Agreement With Syros Pharma	Benzinga
Thursday, 26 May 2022
11:35	Tyme Technologies: Net-Net Biopharma Exploring Strategic Alternatives	Seeking Alpha
Tuesday, 29 March 2022
08:01	Tyme Technologies shares jump premarket on news board to explore strategic options	Market Watch
Friday, 11 February 2022
10:22	Tyme Technologies, Inc.'s (TYME) CEO Richie Cunningham on Q3 2022 Results - Earnings Call Transcript	Seeking Alpha
Thursday, 30 December 2021
00:35	Tyme Technologies Stock (TYME): Why The Price Fell	Pulse2
Tuesday, 7 December 2021
18:47	Tyme Technologies Offers Incredible Risk-Reward	Seeking Alpha
Monday, 8 November 2021
11:08	Tyme Technologies, Inc. (TYME) CEO Richie Cunningham on Q2 2021 Results - Earnings Call Transcript	Seeking Alpha
Tuesday, 2 November 2021
17:30	TYME Technologies, Inc. to Present at Jefferies London Healthcare Conference	Business Wire
Monday, 27 September 2021
06:50	TYME Announces First Patient Dosed in Phase II OASIS Trial Evaluating the Potential Benefits of Oral SM-88 for Patients with Metastatic HR+/HER2- Breast Cancer After Treatment with a CDK4/6 Inhibitor	Business Wire
Thursday, 2 September 2021
06:50	TYME Technologies, Inc. to Present at Upcoming Virtual Healthcare Industry Conferences	Business Wire
Friday, 27 August 2021
18:45	Tyme Technologies: The Market Missed The Bullish Memo	Seeking Alpha

Ideas & Opinions

Seeking Alpha 26 May 2022

Tyme Technologies: Net-Net Biopharma Exploring Strategic Alternatives
Seeking Alpha 7 Dec 2021

Tyme Technologies Offers Incredible Risk-Reward
Seeking Alpha 27 Aug 2021

Tyme Technologies: The Market Missed The Bullish Memo
Seeking Alpha 29 May 2021

Tyme Technologies: Recent Sell-Off Provides Opportunity To Buy At A Discount

Frequently Asked Questions (FAQ)

What's the price of Tyme Technologies stock today?

One share of Tyme Technologies stock can currently be purchased for approximately $0.31.
When is Tyme Technologies's next earnings date?

Unfortunately, Tyme Technologies's (TYME) next earnings date is currently unknown.
Does Tyme Technologies pay dividends?

No, Tyme Technologies does not pay dividends.
What is Tyme Technologies's stock symbol?

Tyme Technologies, Inc. is traded on the NASDAQ under the ticker symbol "TYME".
What is Tyme Technologies's primary industry?

Company operates in the Healthcare sector and Biotechnology industry.
How do i buy shares of Tyme Technologies?

Shares of Tyme Technologies can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Tyme Technologies's key executives?
Tyme Technologies's management team includes the following people:
- Mr. Steven E. Hoffman Co-Founder, Chairman & Chief Science Officer(age: 62, pay: $819,660)
- Mr. James Biehl J.D. Chief Legal Officer & Sec.(age: 61, pay: $645,520)
- Dr. Jonathan M. Eckard Chief Bus. Officer(age: 51, pay: $556,560)
- Mr. Richard Cunningham Chief Executive Officer & Director(age: 54, pay: $355,970)
Is Tyme Technologies founder-led company?

Yes, Tyme Technologies is a company led by its founder Mr. Steven E. Hoffman.
How many employees does Tyme Technologies have?

As Jul 2024, Tyme Technologies employs 13 workers.
When Tyme Technologies went public?

Tyme Technologies, Inc. is publicly traded company for more then 13 years since IPO on 25 May 2012.
What is Tyme Technologies's official website?

The official website for Tyme Technologies is tymeinc.com.
Where are Tyme Technologies's headquarters?

Tyme Technologies is headquartered at 17 State St Fl 7, New York City, NEW YORK.
How can i contact Tyme Technologies?

Tyme Technologies's mailing address is 17 State St Fl 7, New York City, NEW YORK and company can be reached via phone at +1 212 461 2315.

Tyme Technologies, Inc.

tymeinc.com

Exchange:

NASDAQ

Full time employees:

Industry:

Biotechnology

Sector:

Healthcare

Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also developing TYME-19, an oral synthetic member of the bile acid family, which is in preclinical stage for the treatment of SARS CoV-2 diseases; and TYME-18, a CMBT compound that is in preclinical stage for the treatment of inoperable tumors. It has research collaborations with Mayo Clinic to perform in-depth analysis of pancreatic cancer cell gene expression, epigenetic, and metabolism changes from SM-88 treatment; and a research investigator at Georgetown University to examine the effects of SM-88 in breast cancer. The company was formerly known as Global Group Enterprises Corp. The company was incorporated in 2011 and is headquartered in Bedminster, New Jersey. As of September 16, 2022, Tyme Technologies, Inc. operates as a subsidiary of Syros Pharmaceuticals, Inc.

+1 212 461 2315

17 State St Fl 7
New York City, NEW YORK 07921

CIK: 0001537917
ISIN: US90238J1034
CUSIP: 90238J103